Viewpoints
Opinion

BioNTech’s 30 Billion Reasons

BioNTech’s 30 Billion Reasons
A vial and syringe are seen in front of the Pfizer and BioNTech logos in a file photo. Dado Ruvic/Reuters
|Updated:
0:00
Commentary
The real winner in the COVID-19 vaccine sweepstakes is the German company BioNTech, not Pfizer.
Robert Kogon
Robert Kogon
Author
Robert Kogon is a pen name for a widely-published financial journalist, a translator, and researcher working in Europe. He writes at EdV1694.substack.com
twitter
Related Topics